Last summer the mosquito-borne disease killed at least 12 horses in Central and Northern New York and claimed the life of a 4-year-old Oswego County girl.
“EEE is a very serious disease that is nearly always fatal in horses — and nearly 100 percent preventable, if horses are vaccinated,” said Mrs. Ritchie, who attended the clinic. “Yet many horse owners, farmers and others are still unaware of the danger both to their families and to their farm animals. These clinics aim to educate farmers and horse owners, and protect a very valuable investment.”
With no central horse ownership registry in New York state, the state Department of Agriculture and Markets has run its own campaigns aimed at horse owners with mixed results.
Almost half the horses that died from EEE in 2011 were owned by Amish families. Officials estimate that number could be higher because many Amish do not have their horses examined by a veterinarian.
As of 2011, 374 out of 497 regencies and municipalities in Indonesia were malaria endemic. Of a total 1,322,451 suspected cases of malaria, 256,592 were confirmed as positive. The annual parasite incidence (API) rate stands at 1.75 per 1,000 people, meaning that out of every 1,000 people, two of them will suffer from malaria.
In Bangka Belitung, malaria caused by Plasmodium falciparum accounts for 48 percent of total infections, being more prevalent than the P. Vivax strain.
It is official now. The acute encephalitis syndrome(AES) that has killed 233 children in Bihar since May is not Japanese encephalitis, it was announced Thursday.
The ruling has come from the Pune-based National Institute of Virology (NIV).
“In fact the disease remains a mysterious one,” Additional Secretary (Health) R.P. Ojha said.
Grants and funding from the Rocky Mountain Regional Center of Excellence at CSU has supported countless trials and computations that yielded a drug that inhibits the ability of these enzymes to replicate. Simply put, the drug penetrates a cell’s membrane, and then targets and blinds the virus’ protein; thus, stopping the growth of enzymes within.
Orin Levine, executive director of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, says the new vaccine is a potential breakthrough but warned its roll-out may not be straightforward.
First up, the vaccine needs to be given in three installments over the course of a year in order to counter the threat from four different types of dengue virus, none of which confers immunity for the others.
“There are going to be some challenges,” says Levine. “There’s really good economic potential from this vaccine but I think it may take a ramp-up of three to five years.”
In an ideal world, healthcare experts would like a single-dose or, at most, a two-dose vaccine for mass immunization.
A simpler regimen would also be better for travelers, although Pascal Barollier of Sanofi Pasteur, Sanofi’s vaccine arm, says many users will be people making regular trips to see families in Latin America or Asia with time to plan ahead. The military, too, often has lead time for troop movements.
In any case, Sanofi is putting its money where its mouth is by spending 350 million euros on a new dengue vaccine factory near Lyon, which is already in test production.
Colombo residents facilitating the breeding of dengue mosquitoes will be arrested under Act 262 of the Penal Code when a joint operation of 2,000 personnel from the Colombo Municipal Council (CMC), Army, Navy, Air Force and Police conduct an operation on July 1 targeting dengue breeding points in Colombo, CMC Chief Medical Officer Dr Pradeep Kariyawasam said.
“With dengue vaccines, we have a unique opportunity to get ahead of the disease rather than being forced to react and play catch-up,” says Dr. Ciro A. de Quadros, executive vice president of the Sabin Vaccine Institute. “We know that a vaccine is coming as early as 2015, and countries should be encouraged by this new data as they lay the foundations for its adoption.”